Rebecca ten Cate
Professor emeritus Paediatrics, in particular paediatric rheumatology
- Name
- Prof.dr. R. ten Cate
- r.ten_cate@lumc.nl
- ORCID iD
- null
Rebecca ten Cate is Professor in Pediatrics, in particular Pediatric
Pediatric rheumatology
Pediatric rheumatology is a subspecialty of pediatrics. Under the heading of pediatric rheumatology many autoimmune diseases in childhood belong. The majority is acquired but increasingly (mono)genetic disorders are recognised with similar symptoms, the so called autoinflammatory diseases. Rheumatic diseases in childhood are rare. And as symptoms are aspecific it can take a long time before the diagnosis is established. This delay is harmful as early and adequate treatment can prevent damage.
Scientific career
Rebecca ten Cate completed her medical education at the Erasmus University in Rotterdam. She was trained in pediatrics in the Juliana Childrens Hospital in the Hague and the Department of pediatrics of the LUMC. Subsequently she moved to London to be involved in research in the Northwick Park Hospital, where she also was trained in pediatric rheumatology. After returning to the Netherlands she installed outpatient clinics pediatric rheumatology in the LUMC, the Juliana Childrens Hospital and the Sophia Childrens Hospital. Continuation of the research projects led to a thesis in 1991 titled: ‘Pauciarticular Juvenile Idiopathic Arthritis, some clinical aspects’. In 2019 she was appointed Professor in pediatric rheumatology. The title of her oration is ‘Once there was a child with rheumatism….’
After establishing a clinic of pediatric rheumatology in three hospitals and acquiring a teaching position in pediatric rheumatology several research lines were built based up on questions parents and children asked during consultation. Firstly an international genetics study was started aimed at defining prognostic factors for children with juvenile idiopathic arthritis. In the following years two national treatment strategy studies were designed, influencing the treatment protocols for children with juvenile idiopathic arthritis. Considering the aversion of parents and children towards the painful subcutaneous injections required by the modern drugs a research project together with the CHDR was started to investigate wether administration of biologicals via hollow microneedles is an alternative. She published over a hundred peer-reviewed papers, several chapters in textbooks and e-learnings.
Rebecca ten Cate occupied many administrative functions in professional associations, both national and international. She was chair of the section pediatric rheumatology of the Dutch Pediatric Association, secretary and chair of the Dutch Pediatric Rheumatology Association, treasurer and secretary of the Paediatric Rheumatology European Society. She is a member of the Scientific Advisory Board of the CHDR. She is local director of the Pediatric Rheumatology International Trial Organisation. She takes part in several committees of the UCAN-CANDU project, an international study of biomarkers in children with juvenile idiopathic arthritis (member of the Executive Committee, chair of the End-user Advisory Committee and member of the Data-access Committee. She is reviewer of several rheumatological journals.
Professor emeritus Paediatrics, in particular paediatric rheumatology
- Faculteit Geneeskunde
- Divisie 3
- Willem-Alexander Kinderziekenhuis
- Heckert, S.L.; Hissink-Muller, P.C.E.; Berg, J.M. van den; Schonenberg-Meinema, D.; Suijlekom-Smit, L.W.A. van; Rossum, M.A.J. van; Koopman, Y.; Cate, R. ten; Brinkman, D.M.C.; Huizinga, T.W.J.; Allaart, C.F. & Bergstra, S.A. (2023), Patterns of clinical joint inflammation in juvenile idiopathic arthritis, RMD Open 9(1).
- Jacobse J., Voorde W. ten, Tandon A., Romeijn S.G., Grievink H.W., Maaden K. van der, Esdonk M.J. van, Moes D.J.A.R., Loeff F., Bloem K., Vries A. de, Rispens T., Wolbink G., Kam M. de, Ziagkos D., Moerland M., Jiskoot W., Bouwstra J., Burggraaf J., Schrier L., Rissmann R. & Cate R. ten (2021), Comprehensive evaluation of microneedle-based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trial, British Journal of Clinical Pharmacology 87(8): 3162-3176.
- Spekking, K.; Boer, P. de; Bergstra, S.A.; Berg, J.M. van den; Schonenberg-Meinema, D.; Suijlekom-Smit, L.W.A. van; Rossum, M. van; Koopman-Keemink, Y.; Cate, R. ten; Allaart, C.; Brinkman, D.M.C. & Muller, P.C.E.H. (2021), Pain in children with juvenile idiopathic arthritis treated to target: 24 month results from a randomised trial, Annals of the Rheumatic Diseases 80(Suppl 1): 932-932.
- Schonenberg-Meinema, D.; Bergkamp, S.C.; Rashid, A.N.S.; Aa, L.B. van der; Bree, G.J. de; Cate, R. ten; Cutolo, M.; Hak, A.E.; Muller, P.C.E.H.; Onna, M. van; Kuijpers, T.W.; Smith, V. & Berg, J.M. van den (2021), Nailfold capillary abnormalities in childhood-onset systemic lupus erythematosus, Lupus 30(5): 818-827.
- Jacobse, J.; Voorde, W. ten; Tandon, A.; Romeijn, S.G.; Grievink, H.W.; Maaden, K. van der; Esdonk, M.J. van; Moes, D.J.A.R.; Loeff, F.; Bloem, K.; Vries, A. de; Rispens, T.; Wolbink, G.; Kam, M. de; Ziagkos, D.; Moerland, M.; Jiskoot, W.; Bouwstra, J.; Burggraaf, J.; Schrier, L.; Rissmann, R. & Cate, R. ten (2021), Comprehensive evaluation of microneedle-based intradermal adalimumab delivery vs. subcutaneous administration, British Journal of Clinical Pharmacology 87(8).
- Barendregt, A.M.; Veldkamp, S.R.; Muller, P.C.E.H.; Geer, A. van de; Aarts, C.; Gulik, E.C. van; Schilham, M.W.; Kessel, C.; Keizer, M.P.; Hemke, R.; Rashid, A.N.S.; Dolman, K.M.; Schonenberg-Meinema, D.; Cate, R. ten; Berg, J.M. van den; Maas, M. & Kuijpers, T.W. (2020), MRP8/14 and neutrophil elastase for predicting treatment response and occurrence of flare in patients with juvenile idiopathic arthritis, Rheumatology 59(9): 2392-2401.
- Nordal, E.; Pistorio, A.; Rygg, M.; Giancane, G.; Maghnie, M.; Iorgi, N. di; Flemming, K.; Hofer, M.; Melo-Gomes, J.A.; Bica, B.E.R.G.; Brunner, J.; Dannecker, G.; Gerloni, V.; Harjacek, M.; Huppertz, H.I.; Pratsidou-Gertsi, P.; Nielsen, S.; Stanevicha, V.; Cate, R. ten; Vougiouka, O.; Pastore, S.; Simonini, G.; Ravelli, A.; Martini, A.; Ruperto, N. & Paediat Rheumatology Int Trials (2020), Growth and Puberty in Juvenile Dermatomyositis: A Longitudinal Cohort Study, Arthritis Care and Research 72(2): 265-273.
- Klein-Wieringa, I.R.; Brinkman, D.M.C.; Cate, R. ten & Muller, P.C.E.H. (2020), Update on the treatment of nonsystemic juvenile idiopathic arthritis including treatment-to-target: is (drug-free) inactive disease already possible?, Current Opinion in Rheumatology 32(5): 403-413.
- Luijten, M.A.J.; Terwee, C.B.; Oers, H.A. van; Joosten, M.M.H.; Berg, J.M. van den; Schonenberg-Meinema, D.; Dolman, K.M.; Cate, R. ten; Roorda, L.D.; Grootenhuis, M.A.; Rossum, M.A.J. van & Haverman, L. (2020), Psychometric properties of the pediatric patient-reported outcomes measurement information system item banks in a Dutch clinical sample of children with juvenile idiopathic arthritis, Arthritis Care and Research 72(12): 1780-1789.
- Muller, P.H.; Brinkman, D.M.C.; Schonenberg-Meinema, D.; Bosch, W.B. van den; Koopman-Keemink, Y.; Brederije, I.C.J.; Bekkering, P.W.; Kuijpers, T.W.; Rossum, M. van; Suijlekom-Smit, L.W.A. van; Berg, J.M. van den; Boehringer, S.; Allaart, C.F. & Cate, R. ten (2019), Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial, Annals of the Rheumatic Diseases 78(1): 51-59.
- Jacobse, J.; Voorde, W. ten; Rissmann, R.; Burggraaf, J.; Cate, R. ten & Schrier, L. (2019), The effect of repeated methotrexate injections on the quality of life of children with rheumatic diseases, European Journal of Pediatrics 178(1): 17-20.
- Mullerlr, P.C.E.H.; Braak, W.G. van; Schreurs, D.; Nusman, C.M.; Bergstra, S.A.; Hemke, R.; Schonenberg-Meinema, D.; Berg, J.M. van den; Kuijpers, T.W.; Koopman-Keemink, Y.; Rossum, M.A.J. van; Suijlekom-Smit, L.W.A. van; Brinkman, D.M.C.; Allaart, C.F.; Cate, R. ten & Maas, M. (2019), No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis, Pediatric Rheumatology.
- Jacobse, J.; Romeijn, S.G.; Tandon, A.; Voorde, W. ten; Grievink, W.; Rissmann, R.; Burggraaf, J.; Schrier, L.; Cate, R. ten & Jiskoot, W. (2019), Compatibility study of adalimumab and the MicronJet600 hollow microneedle by means of aggregate and particle analysis, British Journal of Clinical Pharmacology 85(7): 1626-1627.
- Mullerlr, P.C.E.H.; Braak, W.G. van; Schreurs, D.; Nusman, C.M.; Bergstra, S.A.; Hemke, R.; Schonenberg-Meinema, D.; Berg, J.M. van den; Kuijpers, T.W.; Koopman-Keemink, Y.; Rossum, M.A.J. van; Suijlekom-Smit, L.W.A. van; Brinkman, D.M.C.; Allaart, C.F.; Cate, R. ten & Maas, M. (2019), No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis, Pediatric Rheumatology 17(1).
- Luijten, M.; Terwee, C.; Oers, H. van; Joosten, M.; Berg, M. van den; Schonenberg-Meinema, D.; Dolman, K.; Cate, R. ten; Roorda, L.; Grootenhuis, M.; Rossum, M. van & Haverman, L. (2019), Psychometric Properties of the Pediatric Patient-Reported Outcomes Measurement Information System (PROMIS (R)) Item Banks in a Dutch Clinical Sample of Children with Juvenile Idiopathic Arthritis, Arthritis and Rheumatology 71.
- Giancane, G.; Lavarello, C.; Pistorio, A.; Oliveira, S.K.; Zulian, F.; Cuttica, R.; Fischbach, M.; Magnusson, B.; Pastore, S.; Marini, R.; Martino, S.; Pagnier, A.; Soler, C.; Stanevicha, V.; Cate, R. ten; Uziel, Y.; Vojinovic, J.; Fueri, E.; Ravelli, A.; Martini, A.; Ruperto, N. & PRINTO (2019), The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients, Pediatric Rheumatology 17.
- P.C.E. Hissink Muller1,2, D.M.C. Brinkman1,3, D. Schonenberg-Meinema4, W. B. van den Bosch1, Y. Koopman-Keemink5, I.C.J. Brederije1, W.P. Bekkering6, T.W. Kuijpers4, M.A.J. van Rossum7,8, L.W.A. van Suijlekom-Smit2, J.M. van den Berg4, S. Boehringer9, C. F. Allaart10 & R. ten Cate1 (2018), Treatment strategies aiming at inactive disease in recent onset Juvenile Idiopathic Arthritis: Clinical outcomes of a randomized trial after 24 months.
- Muller P. Hissink, Brinkman D., Schonenberg-Meinema D., van den Bosch W., Koopman-Keemink Y., Brederije I., Bekkering P., Kuijpers T., van Rossum M., van Suijlekom-Smit L., van den Berg J. M., Boehringer S., Allaart C. F. & ten Cate R. (2018), TREATMENT STRATEGY STUDY IN NEW ONSET DMARD NAIVE JUVENILE IDIOPATHIC ARTHRITIS FIRST RESULTS ON 24 MONTHS CLINICAL OUTCOME, Annals of the Rheumatic Diseases 77: 478-478.
- Gohar, F.; Anink, J.; Moncrieffe, H.; Suijlekom-Smit, L.W.A. van; Prince, F.H.M.; Rossum, M.A.J. van; Dolman, K.M.; Hoppenreijs, E.P.A.H.; Cate, R. ten; Ursu, S.; Wedderburn, L.R.; Horneff, G.; Frosch, M.; Foell, D. & Holzinger, D. (2018), S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis, Journal of Rheumatology 45(4): 547-554.
- Muller, P.C.E.H.; Yildiz, B.; Allaart, C.F.; Brinkman, D.M.C.; Rossum, M. van; Suijlekom-Smit, L.W.A. van; Berg, J.M. van den; Cate, R. ten & Vries, M.C. de (2018), Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise?, BMC Medical Ethics 19.
- Muller, P.C.E.H.; Yildiz, B.; Allaart, C.F.; Brinkman, D.M.C.; Rossum, M. van; Suijlekom-Smit, L.W.A. van; Berg, J.M. van den; Cate, R. ten & Vries, M.C. de (2018), Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise?, BMC Medical Ethics.
- Braak, W.G. van; Schreurs, D.; Muller, P.H.; Nusman, C.; Hemke, R.; Schonenberg, D.; Berg, J. van den; Kuijpers, T.; Koopman, Y.; Rossue, M. van; Suijlekom-Smit, L. van; Brinkman, D.; Allaar, C.; Cate, R. ten & Maas, M. (2018), NO RADIOGRAPHIC WRIST DAMAGE AFTER TARGETED TREATMENT IN JUVENILE IDIOPATHIC ARTHRITIS, Annals of the Rheumatic Diseases 77: 1668-1669.
- Haasnoot, A.M.J.W.; Schilham, M.W.; Kamphuis, S.; Muller, P.C.E.H.; Heiligenhaus, A.; Foell, D.; Minden, K.; Ophoff, R.A.; Radstake, T.R.D.J.; Hollander, A.I. den; Reinards, T.H.C.M.; Hiddingh, S.; Schalij-Delfos, N.E.; Hoppenreijs, E.P.A.H.; Rossum, M.A.J. van; Wouters, C.; Saurenmann, R.K.; Berg, J.M. van den; Wulffraat, N.M.; Cate, R. ten; Boer, J.H. de; Pulit, S.L.; Kuiper, J.J.W. & ICON-JIA Study Grp (2018), Identification of an Amino Acid Motif in HLA-DR1 That Distinguishes Uveitis in Patients With Juvenile Idiopathic Arthritis, Arthritis and Rheumatology 70(7): 1155-1165.
- Haasnoot A. J. W., Schilham M. W., Kamphuis S., Muller P. C. E. Hissink, Heiligenhaus A., Foell D., Minden K., Ophoff R. A., Radstake T. R. D. J., Den Hollander A. I., Reinards T. H. C. M., Hiddingh S., Schalij-Delfos N., Hoppenreijs E. P. A. H., van Rossum M. A. J., Wouters C., Saurenmann R. K., Wulffraat N., ten Cate R., de Boer J. H., Pulit S. L. & Kuiper J. J. W. (2018), An amino acid motif in HLA-DR beta 1 distinguishes patients with uveitis in juvenile idiopathic arthritis, Acta Ophthalmologica 96: 41-41.
- P.C.E. Hissink Muller, D.M.C. Brinkman, D. Schonenberg-Meinema, W.B. van den Bosch, Y. Koopman-Keemink, I.C.J. Brederije, W.P. Bekkering, T.W. Kuijpers, M.A.J. van Rossum, L.W.A. van Suijlekom-Smit, J.M. van den Berg, S. Boehringer, C. F. Allaart & R. ten Cate (2018), TREATMENT STRATEGY STUDY IN NEW ONSET DMARD NAIVE JUVENILE IDIOPATHIC ARTHRITIS FIRST RESULTS ON 24 MONTHS CLINICAL OUTCOME.
- D Schreurs1*, WG van Braak1*, PCE Hissink Muller1*, CM Nusman2, 3, R Hemke2, D Schonenberg3, JM van den Berg3, TW Kuijpers3, Y Koopman4, MAJ van Rossum5, LWA van Suijlekom-Smit6, DMC Brinkman1, CF Allaart7, R ten Cate1** & M Maas2** (2017), No radiographic wrist damage after early aggressive treatment in juvenile idiopathic arthritis 2017.
- Muller, P.C.E.H.; Brinkman, D.M.C.; Schonenberg, D.; Koopman-Keemink, Y.; Brederije, I.C.J.; Bekkering, W.P.; Kuijpers, T.W.; Rossum, M.A.J. van; Suijlekom-Smit, L.W.A. van; Berg, J.M. van den; Allaart, C.F. & Cate, R. ten (2017), A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study, Pediatric Rheumatology 15.
- Hegedus, J.H. von; Madari, Q.S.R.; Muller, P.C.E.H.; Kloppenburg, M.; Toes, R.E.M.; Giera, M.; Huizinga, T.W.J.; Cate, R. ten & Ioan-Facsinay, A. (2017), Characterisation of Lipid Mediator Profile and Immune Cells in Synovial Fluid of Juvenile Idiopathic Arthritis, Arthritis and Rheumatology 69.
- (2017), No radiographic damage after early aggressive treatment in juvenile idiopathic arthritis.
- Muller, P.H.; Meij, T.G.J. de; Westedt, M.; Groot, E.F.J. de; Allaart, C.F.; Brinkman, D.M.C.; Schonenberg-Meinema, D.; Berg, M. van den; Suijlekom-Smit, L.W.A. van; Rossum, M. van; Budding, A.E. & Cate, R. ten (2017), Disturbance of Microbial Core Species in New-Onset Juvenile Idiopathic Arthritis, Journal of Pediatric Infectious Diseases 12(2): 131-135.
- Giancane, G.; Lavarello, C.; Pistorio, A.; Zulian, F.; Magnusson, B.; Avcin, T.; Corona, F.; Gerloni, V.; Pastore, S.; Marini, R.; Martino, S.; Pagnier, A.; Rodiere, M.; Soler, C.; Stanevicha, V.; Cate, R. ten; Uziel, Y.; Vojinovic, J.; Fueri, E.; Ravelli, A.; Martini, A. & Ruperto, N. (2017), Evidence Based Recommendations for Corticosteroid Tapering/Discontinuation in New Onset Juvenile Dermatomyositis Patients from the Printo Trial, Arthritis and Rheumatology 69.
- Nordal, E.; Pistorio, A.; Rygg, M.; Giancane, G.; Hofer, M.; Melo-Gomes, J.A.; Bica, B.; Norambuena, X.; Stanevicha, V.; Cate, R. ten; Vougiouka, O.; Brunner, J.; Dannecker, G.; Pratsidou-Gertsi, P.; Simonini, G.; Venning, H.; Pastore, S.; Ravelli, A.; Martini, A. & Ruperto, N. (2017), Growth and Puberty in Juvenile Dermatomyositis a Longitudinal Multinatinal Cohort Study, Arthritis and Rheumatology 69.
- Guariento, A.; Giancane, G.; Fueri, E.; Zulian, F.; Ravelli, A.; Magnusson, B.; Avcin, T.; Corona, F.; Gerloni, V.; Bracaglia, C.; Cimaz, R.; Meini, A.; Martino, S.; Pagnier, A.; Rodiere, M.; Soler, C.; Stanevicha, V.; Cate, R. ten; Vojinovic, J.; Angioloni, S.; Villa, L.; Pesce, M.; Gregorini, I.; Pallotti, C.; Martini, A.; Pistorio, A. & Ruperto, N. (2017), Quality of Life Evaluation in New Onset Juvenile Dermatomyositis Patients from the Printo Trial, Arthritis and Rheumatology 69.
- Muller, P.H.; Brinkman, D.; Schonenberg-Meinema, D.; Koopman-Keemink, Y.; Bosch, W. van den; Brederije, I.; Bekkering, P.; Kuijpers, T.; Rossum, M. van; Suijlekom-Smit, L. van; Berg, J.M. van den; Allaart, C.F. & Cate, R. ten (2017), Three Treatment Strategies in Recent Onset DMARD Naive Juvenile Idiopathic Arthritis: First Results of Clinical Outcome after 24 Months, Arthritis and Rheumatology 69.
- Petra Hissink Muller, Danielle Brinkman, Dieneke Schonenberg-Meinema, Yvonne Koopman-Keemink, Wytse van den Bosch, Isabel Brederije, Peter Bekkering, Taco Kuijpers, Marion van Rossum, Lisette van Suijlekom-Smit, J Merlijn van den Berg & CF Allaart and Rebecca ten Cate (2017), Abstract Number: 2291 Three Treatment Strategies in Recent Onset DMARD Naive Juvenile Idiopathic Arthritis: First Results of Clinical Outcome after 24 Months.
- Reinards, T.H.C.M.; Albers, H.M.; Brinkman, D.M.C.; Kamphuis, S.S.M.; Rossum, M.A.J. van; Girschick, H.J.; Wouters, C.; Hoppenreijs, E.P.A.H.; Saurenmann, R.K.; Hinks, A.; Ellis, J.A.; Bakker, E.; Verduijn, W.; Slagboom, P.; Huizinga, T.W.J.; Toes, R.E.M.; Houwing-Duistermaat, J.J.; Cate, R. ten & Schilham, M.W. (2015), CD226 (DNAM-1) is associated with susceptibility to juvenile idiopathic arthritis, Annals of the Rheumatic Diseases 74(12): 2193-2198.
- Otten, M.H.; Anink, J.; Prince, F.H.M.; Twilt, M.; Vastert, S.J.; Cate, R. ten; Hoppenreijs, E.P.A.H.; Armbrust, W.; Gorter, S.L.; Pelt, P.A. van; Kamphuis, S.S.M.; Dolman, K.M.; Swart, J.F.; Berg, J.M. van den; Koopman-Keemink, Y.; Rossum, M.A.J. van; Wulffraat, N.M. & Suijlekom-Smit, L.W.A. van (2015), Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register, Annals of the Rheumatic Diseases 74(7): 1379-1386.
- Anink, J.; Suijlekom-Smit, L.W.A. van; Otten, M.H.; Prince, F.H.M.; Rossum, M.A.J. van; Dolman, K.M.; Hoppenreijs, E.P.A.H.; Cate, R. ten; Ursu, S.; Wedderburn, L.R.; Horneff, G.; Frosch, M.; Vogl, T.; Gohar, F.; Foell, D.; Roth, J. & Holzinger, D. (2015), MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis.
- Anink, J.; Prince, F.H.M.; Dijkstra, M.; Otten, M.H.; Twilt, M.; Cate, R. ten; Gorter, S.L.; Koopman-Keemink, Y.; Rossum, M.A.J. van; Hoppenreijs, E.P.A. & Suijlekom-Smit, L.W.A. van (2015), Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register, Rheumatology 54(11): 1964-1969.
- Muller, P.C.E.H.; Brinkman, D.M.C.; Schonenberg, D.; Koopman-Keemink, Y.; Berg, J.M. van den; Bekkering, W.P.; Rossum, M. van; Suijlekom-Smit, L.W. van; Allaart, C.F. & Cate, R. ten (2014), A Comparison of Three Treatment Strategies in Recent Onset DMARD Naive Juvenile Idiopathic Arthritis: 3-Months Results of the BeSt for Kids-Study., Arthritis and Rheumatology 66(12): 3529-3530.
- Anink, J.; Otten, M.H.; Suijlekom-Smit, L.W.A. van; Rossum, M.A.J. van; Dolman, K.M.; Hoppenreijs, E.P.A.; Cate, R. ten; Ursu, S.; Wedderburn, L.R.; Horneff, G.; Vogl, T.; Foll, D.; Roth, J. & Holzinger, D. (2014), MRP8/14 Serum Level As Predictor of Response to Starting and Stopping Anti-TNF Treatment in Non-Systemic Juvenile Idiopathic Arthritis., Arthritis and Rheumatology 66: S414-S414.
- Albers, H.M.; Reinards, T.H.C.M.; Brinkman, D.M.C.; Kamphuis, S.S.M.; Rossum, M.A.J. van; Hoppenreijs, E.P.A.H.; Girschick, H.J.; Wouters, C.; Saurenmann, R.K.; Bakker, E.; Verduijn, W.; Slagboom, P.; Huizinga, T.W.J.; Toes, R.E.M.; Houwing-Duistermaat, J.J.; Cate, R. ten & Schilham, M.W. (2014), Genetic variation in VTCN1 (B7-H4) is associated with course of disease in juvenile idiopathic arthritis, Annals of the Rheumatic Diseases 73(6): 1198-1201.
- Anink, J.; Prince, F.; Dijkstra, M.; Otten, M.H.; Twilt, M.; Cate, R. ten; Gorter, S.; Koopman-Keemink, Y.; Rossum, M.A.J. van; Hoppenreijs, E.P.A. & Suijlekom-Smit, L.W.A. van (2014), Long Term Functional Outcome and Quality of Life of Patients with Refractory Juvenile Idiopathic Arthritis Treated with Etanercept: Results of the Dutch Arthritis and Biologicals in Children Register., Arthritis and Rheumatology 66: S125-S125.
- Otten, M.H.; Anink, J.; Prince, F.H.; Twilt, M.; Vastert, S.J.; Cate, R. ten; Hoppenreijs, E.P.; Armbrust, W.; Gorter, S.L.; Pelt, P.A. van; Kamphuis, S.; Dolman, K.M.; Swart, J.F.; Berg, J.M. van den; Koopman-Keemink, Y.; Rossum, M.A. van; Wulffraat, N.M. & Suijlekom-Smit, L.W. van (2013), TRENDS IN PRESCRIPTION OF BIOLOGICS AND OUTCOMES OF JUVENILE IDIOPATHIC ARTHRITIS; RESULTS OF THE DUTCH NATIONAL ARTHRITIS AND BIOLOGICALS IN CHILDREN REGISTER, Annals of the Rheumatic Diseases 72: 154-154.
- Anink, J.; Otten, M.H.; Prince, F.H.M.; Hoppenreijs, E.P.A.H.; Wulffraat, N.M.; Swart, J.F.; Cate, R. ten; Rossum, M.A.J. van; Berg, J.M. van den; Dolman, K.M.; Koopman-Keemink, Y.; Armbrust, W.; Kamphuis, S.; Pelt, P.A. van; Gorter, S.L. & Suijlekom-Smit, L.W.A. van (2013), Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register, Rheumatology 52(4): 712-717.
- Anink, J.; Otten, M.H.; Gorter, S.L.; Prince, F.H.M.; Rossum, M.A.J. van; Berg, J.M. van den; Pelt, P.A. van; Kamphuis, S.; Brinkman, D.M.C.; Swen, W.A.A.; Swart, J.F.; Wulffraat, N.M.; Dolman, K.M.; Koopman-Keemink, Y.; Hoppenreijs, E.P.A.H.; Armbrust, W.; Cate, R. ten & Suijlekom-Smit, L.W.A. van (2013), Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?, Rheumatology 52(9): 1674-1679.
- Muller, P.C.E.H.; Budding, A.E.; Allaart, C.F.; Brinkman, D.M.C.; Kuijpers, T.W.; Westedt, M.; Berg, J.M. van den; Suijlekom-Smit, L.W.A. van; Rossum, M.A.J. van; Meij, T.G.J. de & Cate, R. ten (2013), Intestinal Microbiome In Polyarticular Juvenile Idiopathic Arthritis: A PILOT Study, Arthritis and Rheumatism 65: S934-S934.
- Otten, M.H.; Prince, F.H.M.; Anink, J.; Cate, R. ten; Hoppenreijs, E.P.A.H.; Armbrust, W.; Koopman-Keemink, Y.; Pelt, P.A. van; Kamphuis, S.; Gorter, S.L.; Dolman, K.M.; Swart, J.F.; Berg, J.M. van den; Wulffraat, N.M.; Rossum, M.A.J. van & Suijlekom-Smit, L.W.A. van (2013), Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register, Annals of the Rheumatic Diseases 72(5): 721-727.
- Muller, P.C.E.H.; Anink, J.; Shi, J.; Levarht, E.W.N.; Reinards, T.H.C.M.; Otten, M.H.; Tol, M.J.D. van; Jol-van der Zijde, C.M.; Brinkman, D.M.C.; Allaart, C.F.; Hoppenreijs, E.P.; Koopman-Keemink, Y.; Kamphuis, S.S.M.; Dolman, K.; Berg, J.M. van den; Rossum, M.A.J. van; Suijlekom-Smit, L.W.A. van; Schilham, M.W.; Huizinga, T.W.J.; Toes, R.E.M.; Cate, R. ten & Trouw, L.A. (2013), Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients, Annals of the Rheumatic Diseases 72(12): 2053-2055.
- Calkoen, F.G.J.; Brinkman, D.M.C.; Vervat, C.; Ostaijen-Ten Dam, M.M. van; Cate, R. ten; Tol, M.J.D. van & Ball, L.M. (2013), Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses, Cytotherapy 15(3): 280-291.
- Holzinger, D.; Frosch, M.; Kastrup, A.; Prince, F.H.M.; Otten, M.H.; Suijlekom-Smit, L.W.A. van; Cate, R. ten; Hoppenreijs, E.P.A.H.; Hansmann, S.; Moncrieffe, H.; Ursu, S.; Wedderburn, L.R.; Roth, J.; Foell, D. & Wittkowski, H. (2012), The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis, Annals of the Rheumatic Diseases 71(6): 974-980.
- Janssen, C.E.I.; Rose, C.D.; Hertogh, G. de; Martin, T.M.; Meunier, B.B.; Cimaz, R.; Harjacek, M.; Quartier, P.; Cate, R. ten; Thomee, C.; Desmet, V.J.; Fischer, A.; Roskams, T. & Wouters, C.H. (2012), Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease.
- Muller, P.C.E.H.; Yildiz, B.; Allaart, C.F.; Brinkman, D.M.C.; Rossum, M.A.J. van; Berg, J.M. van den; Suijlekom-Smit, L.W.A. van; Cate, R. ten & Vries, M.C. de (2012), Randomized Clinical Trial in Pediatric Rheumatology: Are Parents and Patients in Equipoise?, Arthritis and Rheumatism 64(10): S849-S849.
- P. C. E. Hissink Muller, B. Yildiz,C. F. Allaart,D. M. C. Brinkman,M. A. J. Van Rossum, J. M. Van den Berg, L. W. A. Van Suijlekom-Smit, R. Ten Cate & M. C. de Vries (2012), Randomized Clinical Trial in Pediatric Rheumatology: Are Parents and Patients in Equipoise?
- Otten, M.H.; Prince, F.H.M.; Twilt, M.; Cate, R. ten; Armbrust, W.; Hoppenreijs, E.P.A.H.; Koopman-Keemink, Y.; Wulffraat, N.M.; Gorter, S.L.; Dolman, K.M.; Swart, J.F.; Berg, J.M. van den; Rossum, M.A.J. van & Suijlekom-Smit, L.W.A. van (2011), Tumor Necrosis Factor-blocking Agents for Children with Enthesitis-related Arthritis - Data from the Dutch Arthritis and Biologicals in Children Register, 1999-2010.
- Otten, M.H.; Prince, F.H.M.; Anink, J.; Rossum, M.A.J. van; Hoppenreijs, E.P.A.H.; Gorter, S.L.; Armbrust, W.; Dolman, K.M.; Koopman-Keemink, Y.; Swart, J.F.; Berg, J.M. van den; Wulffraat, N.M.; Cate, R. ten & Suijlekom-Smit, L.W.A. (2011), Effectiveness and Safety of Switching Between Biologics in Juvenile Idiopathic Arthritis; Results From the Dutch ABC Register., Arthritis and Rheumatism 63(10): S107-S107.
- Otten, M.H.; Prince, F.H.M.; Armbrust, W.; Cate, R. ten; Hoppenreijs, E.P.A.H.; Twilt, M.; Koopman-Keemink, Y.; Gorter, S.L.; Dolman, K.M.; Swart, J.F.; Berg, J.M. van den; Wulffraat, N.M.; Rossum, M.A.J. van & Suijlekom-Smit, L.W.A. van (2011), Etanercept in Juvenile Idiopathic Arthritis: Who Will Benefit? Results From the Dutch ABC Register, Arthritis and Rheumatism 63(10): S96-S96.
- Brinkman, D.M.C.; Calkoen, F.G.J.; Vervat, C.; Plomp, A.; Cate, R. ten; Tol, M.J.D. van & Ball, L.M. (2011), Biological and immunological characteristics of bone marrow and pulpa derived mesenchymal stroma cells in children with juvenile idiopathic arthritis, Clinical and Experimental Rheumatology 29(2): 409-409.
- Otten, M.H.; Prince, F.H.M.; Armbrust, W.; Cate, R. ten; Hoppenreijs, E.P.A.H.; Twilt, M.; Koopman-Keemink, Y.; Gorter, S.L.; Dolman, K.M.; Swart, J.F.; Berg, J.M. van den; Wulffraat, N.M.; Rossum, M.A.J. van & Suijlekom-Smit, L.W.A. van (2011), Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis, Journal of the American Medical Association 306(21): 2340-2347.
- Prince, F.H.M.; Bekker-Grob, E.W. de; Twilt, M.; Rossum, M.A.J. van; Hoppenreijs, E.P.A.H.; Cate, R. ten; Koopman-Keemink, Y.; Gorter, S.L.; Raat, H. & Suijlekom-Smit, L.W.A. van (2011), An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register, Rheumatology 50(6): 1131-1136.
- Otten, M.H.; Prince, F.H.M.; Cate, R. ten; Rossum, M.A.J. van; Twilt, M.; Hoppenreijs, E.P.A.H.; Koopman-Keemink, Y.; Oranje, A.P.; Waard-van der Spek, F.B. de; Gorter, S.L.; Armbrust, W.; Dolman, K.M.; Wulffraat, N.M. & Suijlekom-Smit, L.W.A. van (2011), TNF-blocking agents in Juvenile Psoriatic Arthritis: are they effective?, Clinical and Experimental Rheumatology 29(2): 456-456.
- Otten, M.H.; Prince, F.H.M.; Cate, R. ten; Rossum, M.A.J. van; Twilt, M.; Hoppenreijs, E.P.A.H.; Koopman-Keemink, Y.; Oranje, A.P.; Waard-van der Spek, F.B. de; Gorter, S.L.; Armbrust, W.; Dolman, K.M.; Wulffraat, N.M. & Suijlekom-Smit, L.W.A. van (2011), Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?, Annals of the Rheumatic Diseases 70(2): 337-340.
- Otten, M.H.; Twilt, M.; Prince, E.H.M.; Armbrust, W.; Cate, R. ten; Gorier, S.L.; Koopman-Keemink, Y.; Swart, J.F.; Dolman, K.M.; Hoppenreijs, E.P.A.H.; Wulffraat, N.M.; Rossum, M.A.J. van & Suijlekom-Smit, L.W.A. van (2011), Effectiveness of etanercept in children with Enthesitis Related Arthritis, Clinical and Experimental Rheumatology 29(2): 457-457.
- Prince, F.H.M.; Bekker-Grob, E.W. de; Twilt, M.; Rossum, M.A.J. van; Hoppenreijs, E.P.A.H.; Cate, R. ten; Koopman-Keemink, Y.; Gorter, S.; Raat, H. & Suijlekom-Smit, L.W.A. van (2011), An analysis of the costs and treatment success of etanercept in Juvenile Idiopathic Arthritis, Clinical and Experimental Rheumatology 29(2): 443-443.
- Albers, H.M.; Brinkman, D.M.C.; Kamphuis, S.S.M.; Suijlekom-Smit, L.W.A. van; Rossum, M.A.J. van; Hoppenreijs, E.P.A.H.; Girschick, H.J.; Wouters, C.; Saurenmann, R.K.; Houwing-Duistermaat, J.J.; Huizinga, T.W.J.; Schilham, M.W. & Cate, R. ten (2010), Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritis.
- Prince, F.H.M.; Geerdink, L.M.; Borsboom, G.J.J.M.; Twilt, M.; Rossum, M.A.J. van; Hoppenreijs, E.P.A.H.; Cate, R. ten; Koopman-Keemink, Y.; Santen-Hoeufft, M. van; Raat, H. & Suijlekom-Smit, L.W.A. van (2010), Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis, Annals of the Rheumatic Diseases 69(1): 138-142.
- Saad-Magalhaes, C.; Pistorio, A.; Ravelli, A.; Filocamo, G.; Viola, S.; Brik, R.; Mihaylova, D.; Cate, R. ten; Andersson-Gare, B.; Ferriani, V.; Minden, K.; Hashkes, P.; Rygg, M.; Sauvain, M.J.; Venning, H.; Martini, A.; Ruperto, N. & PRINTO (2010), Does removal of aids/devices and help make a difference in the Childhood Health Assessment Questionnaire disability index?, Annals of the Rheumatic Diseases 69(1): 82-87.
- Otten, M.H.; Prince, F.H.M.; Twilt, M.; Rossum, M.A.J. van; Armbrust, W.; Hoppenreijs, E.P.A.H.; Kamphuis, S.; Koopman-Keemink, Y.; Wulffraat, N.M.; Gorter, S.L.; Cate, R. ten & Suijlekom-Smit, L.W.A. van (2010), Delayed Clinical Response in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept, Journal of Rheumatology 37(3): 665-667.
- Albers, H.M.; Brinkman, D.M.C.; Kamphuis, S.S.M.; Suijlekom-Smit, L.W.A. van; Rossum, M.A.J. van; Hoppenreijs, E.P.A.H.; Girschick, H.J.; Wouters, C.; Saurenmann, R.K.; Houwing-Duistermaat, J.J.; Huizinga, T.W.J.; Schilham, M.W. & Cate, R. ten (2010), Clinical Course and Prognostic Value of Disease Activity in the First Two Years in Different Subtypes of Juvenile Idiopathic Arthritis, ARTHRITIS CARE & RESEARCH 62(2): 204-212.
- Otten, M.H.; Cransberg, K.; Rossum, M.A.J. van; Groothoff, J.W.; Kist-van Holthe, J.E.; Cate, R. ten & Suijlekom-Smit, L.W.A. van (2010), Disease activity patterns in juvenile systemic lupus erythematosus and its relation to early aggressive treatment, Lupus 19(13): 1550-1556.
- Prince FHM, Twilt M, Simon SCM, van Rossum MAJ, Armbrust W, Hoppenreijs EPAH, Kamphuis S, van Santen-Hoeufft M, Koopman-Keemink Y, Wulffraat NM, ten Cate R & van Suijlekom-Smit LWA (2009), When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis, Annals of the Rheumatic Diseases 68(7): 1228-1229.
- Prince FHM, Twilt M, ten Cate R, van Rossum MAJ, Armbrust W, Hoppenreijs EPAH, van Santen-Hoeufft M, Koopman-Keemink Y, Wulffraat NM, van Suijlekom-Smit LWA & Hoppenreijs EPAH (2009), Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register, Annals of the Rheumatic Diseases 68(5): 635-641.
- Albers HM, Kurreeman FAS, Stoeken-Rijsbergen G, Brinkman DMC, Kamphuis SSM, van Rossum MAJ, Girschick HJ, Wouters C, Saurenmann RK, Hoppenreijs E, Slagboom P, Houwing-Duistermaat JJ, Verduijn W, Huizinga TWJ, ten Cate R, Toes REM & Schilham MW (2009), Association of the Autoimmunity Locus 4q27 With Juvenile Idiopathic Arthritis, Arthritis and Rheumatism 60(3): 901-904.
- Albers HM, Wessels JAM, van der Straaten RJHM, Brinkman DMC, Suiilekom-Smit LWA, Kamphuis SSM, Girschick HJ, Wouters C, Schilham MW & le Cessie S (2009), Time to Treatment as an Important Factor for the Response to Methotrexate in Juvenile Idiopathic Arthritis, Arthritis and Rheumatism 61(1): 46-51.
- Garnefski N, Koopman H, Kraaij V & ten Cate R (2009), Brief report: Cognitive emotion regulation strategies and psychological adjustment in adolescents with a chronic disease.
- Prince FHM, Ferket IS, Kamphuis S, Armbrust W, ten Cate R, Hoppenreijs EPAH, Koopman-Keemink Y, van Rossum MAJ, van Santen-Hoeufft M, Twilt M & van Suijlekom-Smit LWA (2008), Development of a web-based register for the Dutch national study on biologicals in JIA: www.ABC-register.nl, Rheumatology 47(9).
- Albers HM, Kurreeman FAS, Houwing-Duistermaat JJ, Brinkman DMC, Kamphuis SSM, Girschick HJ, Wouters C, Van Rossum MAJ, Verduijn W, Toes REM, Huizinga TWJ, Schilham MW & ten Cate R (2008), The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis, Annals of the Rheumatic Diseases 67(11).
- Albers H, Kurreeman F, Houwing-Duistermaat J, Brinkman D, Kamphuis S, Girschick H, Wouters C, van Rossum M, Verduyn W, Toes R, Huizinga T, Schilham M & ten Cate R (2008), The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis, Arthritis and Rheumatism 58(9).
- Ruperto N, Ravelli A, Pistorio A, Ferriani V, Calvo I, Ganser G, Brunner J, Dannecker G, Silva CA, Stanevicha V, Ten Cate R, van Suijlekom-Smit LWA, Voygioyka O, Fischbach M, Foeldvari I, Hilario O, Modesto C, Saurenmann RK, Sauvain MJ, Scheibel I, Sommelet D, Tambic-Bukovac L, Barcellona R, Brik R, Ehl S, Jovanovic M, Rovensky J, Bagnasco F, Lovell DJ & Martini A (2008), The Provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: A prospective validation study, Arthritis and Rheumatism 59(1).
- Brinkman DMC, Zijde CMJVD, ten Dam MM, Boekhorst PAWT, ten Cate R, Wulffraat NM, Hintzen RQ, Vossen JM & van Tol MJD (2007), Resetting the adaptive immune system after autologous stem cell transplantation: Lessons from responses to vaccines, Journal of Clinical Immunology 27(6).
- Bekkering WP, ten Cate R, van Rossum MAJ & Vlieland TPMV (2007), A comparison of the measurement properties of the Juvenile Arthritis Functional Assessment Scale with the childhood health assessment questionnaire in daily practice, Clinical Rheumatology 26(11).
- Twilt M, Arends LR, ten Cate R & van Suijlekom-Smit LWA (2007), Incidence of temporomandibular involvement in juvenile idiopathic arthritis, Scandinavian Journal of Rheumatology 36(3).
- van Rossum MAJ, van Soesbergen RM, Boers M, Zwinderman AH, Fiselier TJW, Franssen MJAM, ten Cate R, van Suijlekom-Smit LWA, Wulffraat NM, van Luijk WHJ, Oostveen JCM, Kuis W & Dijkmans BAC (2007), Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment, Annals of the Rheumatic Diseases 66(11).
- Brinkman DMC, de Kleer IM, ten Cate R, van Rossum MAJ, Bekkering WP, Fasth A, van Tol MJD, Kuis W, Wulffraat NM & Vossen JM (2007), Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis - Long-term followup of a prospective clinical trial, Arthritis and Rheumatism 56(7).
- Twilt M, Brinkman DMC, Hamdy NAT & Ten Cate R (2007), Beneficial clinical response to intravenously administered pamidronate in children with chronic recurrent multifocal osteomyelitis, Annals of the Rheumatic Diseases 66.
- de Kort SWK, van Rossum MAJ & ten Cate R (2006), Infliximab in a child with therapy-resistant systemic vasculitis, Clinical Rheumatology 25(5).
- Grote FK, van Suijlekom-Smit LWA, Mul D, Hop WCJ, ten Cate R, Oostdijk W, Van Luijk W, Jansen-van Wijngaarden CJA & Keizer-Schrama SMPFD (2006), Growth hormone treatment in children with rheumatic disease, corticosteroid induced growth retardation, and osteopenia, Archives of Disease in Childhood 91(1).
- van Rossum MAJ, Boers M, Zwinderman AH, van Soesbergen RM, Wieringa H, Fiselier TJW, Franssen MJAM, ten Cate R, van Suijlekom-Smit LWA, Wulffraat NM, van Luijk WHJ, Oostveen JCM, Kuis W & Dijkmans BAC (2005), Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis - Introduction of the Dijkstra composite score, Arthritis and Rheumatism 52(9).
- ten Cate R, Nibbering PH & Bredius RGM (2004), Therapy-refractory systemic juvenile idiopathic arthritis successfully treated with statins, Rheumatology 43(7).
- Kreder NC, ten Cate R, Rodermond HM, van Bree C, Franken NAP, Zdzienicka MZ & Haveman J (2004), Cellular response to pulsed low-dose rate irradiation in X-ray sensitive hamster mutant cell lines, Journal of Radiation Research 45(3).
- Twilt M, Mobers SMLM, Arends LR, ten Cate R & van Suijlekom-Smit LWA (2004), Temporomandibular involvement in juvenile idiopathic arthritis, Journal of Rheumatology 31(7).
- ten Cate R, Smiers FJ, Bredius RGM, Lankester AC, van Suijlekom-Smit LWA, Huizinga TW & Egeler RM (2004), Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus, Rheumatology 43(2).
- Janssen R, Verhard E, Lankester A, ten Cate R & van Dissel JT (2004), Enhanced interleukin-1 beta and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome, Arthritis and Rheumatism 50(10).
- de Kleer IM, Brinkman DMC, Ferster A, Abinun M, Quartier P, van der Net J, ten Cate R, Wedderburn LR, Horneff G, Oppermann J, Zintl F, Foster HE, Prieur AM, Fasth A, van Rossum MAJ, Kuis W & Wulffraat NM (2004), Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity, Annals of the Rheumatic Diseases 63(10).
- Twilt M, van der Giesen E, Mobers SMLM, ten Cate R & van Suijlekom-Smit LWA (2003), Abrupt condylar destruction of the mandibula in juvenile idiopathic arthritis, Annals of the Rheumatic Diseases 62(4).
- Steens SCA, Bosma GPT, ten Cate R, Doornbos J, Kros JM, Laan LAEM, Steup-Beekman GM, van Buchem MA & Huizinga TWJ (2003), A neuroimaging follow up study of a patient with juvenile central nervous system systemic lupus erythematosus, Annals of the Rheumatic Diseases 62(6).
- Cimaz R, Casadei A, Rose C, Bartunkova J, Sediva A, Falcini F, Picco P, Taglietti M, Zulian F, Ten Cate R, Sztajnbok FR, Voulgari PV & Drosos AA (2003), Primary Sjogren syndrome in the paediatric age: a multicentre survey, European Journal of Pediatrics 162(10).
- Wulffraat NM, Brinkman D, Ferster A, Opperman J, ten Cate R, Wedderburn L, Foster H, Abinun M, Prieur AM, Horneff G, Zintl F, de Kleer I & Kuis W (2003), Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis, Bone Marrow Transplantation 32.
- Twilt M, van den Berg MS, van Meurs JC, ten Cate R & van Suijlekom-Smit LWA (2003), Persisting uveitis antedating psoriasis in two boys, European Journal of Pediatrics 162(9).
- van Rossum MAJ, Zwinderman AH, Boers M, Dijkmans BAC, van Soesbergen RM, Fiselier TJW, Franssen MJAM, ten Cate R, van Suijlekom-Smit LWA, Wulffraat NM, Kuis W, van Luijk WHJ, Oostveen JCM & Dijkstra PF (2003), Radiologic features in juvenile idiopathic arthritis - A first step in the development of a standardized assessment method, Arthritis and Rheumatism 48(2).
- van Rossum M, van Soesbergen R, de Kort S, ten Cate R, Zwinderman AH, de Jong B, Dijkmans B & van Venrooij WJ (2003), Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis, Journal of Rheumatology 30(4).
- Mul D, van Suijlekom-Smit LWA, ten Cate R, Bekkering WP & Keizer-Schrama SMPFD (2002), Bone mineral density and body composition and influencing factors in children with rheumatic diseases treated with corticosteroids, Journal of Pediatric Endocrinology and Metabolism 15(2).
- ten Cate R, Brinkman DMC, van Rossum MAJ, Lankester AC, Bredius RGM, Egeler MRM, van Tol MJD & Vossen JM (2002), Macrophage activation syndrome after autologous stem cell transplantation for systemic juvenile idiopathic arthritis, European Journal of Pediatrics 161(12).
- Wulffraat M, de Kleer I, Brinkman D, ten Cate R, van der Net JJ, Rijkers GT & Kuis W (2002), Autologous stem cell transplantation for refractory juvenile idiopathic artrhitis: Current results and perspectives, Transplantation Proceedings 34(7).
- Brinkman DMC, ten Cate R, Vossen JM, Smeets TJM, Kraan MC & Tak PP (2002), Decrease in synovial cellularity and cytokine expression after autologous stem cell transplantation in patients with juvenile idiopathic arthritis, Arthritis and Rheumatism 46(4).
- ten Cate R, van Suijlekom-Smit LWA, Brinkman DMC, Bekkering WP, Jansen-van Wijngaarden CJA & Vossen JM (2002), Etanercept in four children with therapy-resistant systemic juvenile idiopathic arthritis, Rheumatology 41(2).
- Wulffraat N, van der Net JJ, Ruperto N, Kamphuis S, Prakken BJ, Ten Cate R, Van Soesbergen RM, Van Rossum MA, Raat H, Landgraf JM & Kuis W (2001), The Dutch version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ), Clinical and Experimental Rheumatology 19(4).
- Bekkering WP, ten Cate R, van Suijlekom-Smit LWA, Mul D, van der Velde EA & van den Ende CHM (2001), The relationship between impairments in joint function and disabilities in independent function in children with systemic juvenile idiopathic arthritis, Journal of Rheumatology 28(5).
- van Rossum MAJ, Fiselier TJW, Franssen MJAN, ten Cate R, van Suijlekom-Smit LWA, Wulffraat NM, van Luijk WHJ, Oostveen JCM, Kuis W, Dijkmans BAC & van Soesbergen RM (2001), Effects of sulfasalazine treatment on serum immunoglobulin levels in children with juvenile chronic arthritis, Scandinavian Journal of Rheumatology 30(1).